 Marta Rowh
Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Military Personnel | 1 | 2023 | 515 | 0.520 |
Why?
| | B-Lymphocytes | 3 | 2013 | 815 | 0.470 |
Why?
| | Translocation, Genetic | 2 | 2013 | 96 | 0.460 |
Why?
| | Cell Lineage | 2 | 2013 | 332 | 0.340 |
Why?
| | Lymphoma, B-Cell | 1 | 2011 | 105 | 0.330 |
Why?
| | Forkhead Transcription Factors | 1 | 2008 | 184 | 0.280 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 509 | 0.270 |
Why?
| | Immune Tolerance | 1 | 2008 | 355 | 0.250 |
Why?
| | Trichomonas Vaginitis | 1 | 2025 | 4 | 0.240 |
Why?
| | Vaginosis, Bacterial | 1 | 2025 | 12 | 0.240 |
Why?
| | Trichomonas vaginalis | 1 | 2025 | 13 | 0.240 |
Why?
| | Crowding | 1 | 2025 | 35 | 0.230 |
Why?
| | T-Lymphocyte Subsets | 2 | 2025 | 412 | 0.220 |
Why?
| | Disaster Planning | 1 | 2025 | 82 | 0.220 |
Why?
| | Mass Vaccination | 1 | 2023 | 16 | 0.210 |
Why?
| | Medically Underserved Area | 1 | 2023 | 84 | 0.200 |
Why?
| | Cytokines | 1 | 2025 | 2013 | 0.130 |
Why?
| | Pandemics | 1 | 2023 | 1482 | 0.110 |
Why?
| | Vaccination | 1 | 2023 | 1347 | 0.110 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 1896 | 0.110 |
Why?
| | Germ Cells | 1 | 2013 | 59 | 0.100 |
Why?
| | Oncogenes | 1 | 2013 | 112 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 131 | 0.100 |
Why?
| | Lymphoma | 1 | 2013 | 196 | 0.100 |
Why?
| | Genes, Immunoglobulin | 1 | 2011 | 28 | 0.090 |
Why?
| | DNA End-Joining Repair | 1 | 2011 | 18 | 0.090 |
Why?
| | Genes, myc | 1 | 2011 | 49 | 0.090 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2011 | 80 | 0.090 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2011 | 37 | 0.090 |
Why?
| | Burkitt Lymphoma | 1 | 2011 | 56 | 0.090 |
Why?
| | United States | 3 | 2025 | 13828 | 0.090 |
Why?
| | Immunoglobulin Joining Region | 1 | 2009 | 10 | 0.080 |
Why?
| | Antibody Diversity | 1 | 2009 | 16 | 0.080 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2009 | 15 | 0.080 |
Why?
| | Feedback, Physiological | 1 | 2009 | 76 | 0.080 |
Why?
| | Forkhead Box Protein O1 | 1 | 2008 | 21 | 0.070 |
Why?
| | Histones | 1 | 2013 | 588 | 0.070 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2009 | 336 | 0.070 |
Why?
| | Contraception | 1 | 2009 | 153 | 0.070 |
Why?
| | Abortion, Induced | 1 | 2009 | 100 | 0.070 |
Why?
| | Chromatin | 1 | 2009 | 478 | 0.060 |
Why?
| | Education, Medical | 1 | 2009 | 244 | 0.060 |
Why?
| | Georgia | 1 | 2025 | 79 | 0.060 |
Why?
| | Mass Casualty Incidents | 1 | 2025 | 36 | 0.060 |
Why?
| | Vagina | 1 | 2025 | 174 | 0.050 |
Why?
| | Humans | 6 | 2025 | 129271 | 0.050 |
Why?
| | Animals | 4 | 2013 | 35309 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2008 | 2375 | 0.040 |
Why?
| | Mice | 3 | 2013 | 16915 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2013 | 2117 | 0.030 |
Why?
| | Signal Transduction | 1 | 2009 | 4926 | 0.030 |
Why?
| | Suppression, Genetic | 1 | 2013 | 25 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2013 | 32 | 0.030 |
Why?
| | Chromosomes, Mammalian | 1 | 2013 | 25 | 0.030 |
Why?
| | Haploinsufficiency | 1 | 2013 | 48 | 0.030 |
Why?
| | Clone Cells | 1 | 2013 | 262 | 0.030 |
Why?
| | Gene Amplification | 1 | 2013 | 105 | 0.030 |
Why?
| | Female | 3 | 2025 | 68556 | 0.030 |
Why?
| | Transgenes | 1 | 2013 | 177 | 0.020 |
Why?
| | Gene Deletion | 1 | 2013 | 380 | 0.020 |
Why?
| | HIV Infections | 1 | 2025 | 2721 | 0.020 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 46 | 0.020 |
Why?
| | Immunoglobulin Variable Region | 1 | 2009 | 79 | 0.020 |
Why?
| | Reproductive Medicine | 1 | 2009 | 14 | 0.020 |
Why?
| | Sex Education | 1 | 2009 | 28 | 0.020 |
Why?
| | Sildenafil Citrate | 1 | 2009 | 59 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2009 | 265 | 0.020 |
Why?
| | Germ-Line Mutation | 1 | 2009 | 140 | 0.020 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2009 | 89 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 12392 | 0.020 |
Why?
| | Sulfones | 1 | 2009 | 108 | 0.020 |
Why?
| | Purines | 1 | 2009 | 172 | 0.020 |
Why?
| | Canada | 1 | 2009 | 350 | 0.020 |
Why?
| | Male | 2 | 2011 | 63517 | 0.020 |
Why?
| | Reproduction | 1 | 2009 | 197 | 0.020 |
Why?
| | Piperazines | 1 | 2009 | 341 | 0.020 |
Why?
| | Counseling | 1 | 2009 | 383 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 820 | 0.010 |
Why?
| | Sexual Behavior | 1 | 2009 | 481 | 0.010 |
Why?
| | Students, Medical | 1 | 2009 | 315 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5439 | 0.010 |
Why?
| | Adult | 1 | 2025 | 35497 | 0.010 |
Why?
| | Curriculum | 1 | 2009 | 910 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2009 | 1887 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 6543 | 0.010 |
Why?
|
|
Rowh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|